4,4-dioxo-5,6-dihydro-[1,4,3]oxathiazines, a novel class of 11 -hsd1 inhibitors for the treatment of diabetes Deposition Author(s): Engel, C.K. , Loenze, P. , Schimanski-Breves, S. , Vonderheyden, C.
Date: 2013-04-08 Method: X-RAY DIFFRACTION Resolution: 2.21 Å Organism(s): Mus Musculus Sequences Data: 4K26_A , 4K26_B